Maternal plasma levels of soluble SDC-1 rise approximately 50-fold with gestation and revert postpartum. Women who later develop preeclampsia have lower levels of soluble SDC-1 in maternal plasma at the gestational age of 20 weeks (before clinical disease onset) compared to women with uncomplicated pregnancy or gestational hypertension. Here, SDC1 is linked to preeclampsia.